Table 1 Pre-treatment parameters baseline patient characteristics
HLA-DRB1*04 allele type | HLA-DRB1*04 −/− | HLA-DRB1*04 +/− | HLA-DRB1*04 +/+ | p |
|---|---|---|---|---|
Age (years) | 47.83 ± 23.78 | 50.73 ± 17.53 | 49.52 ± 14.24 | 0.793* |
Sex (male:female) | 3:3 | 9:5 | 3:5 | 0.47** |
Refractive error (diopters) | −0.93 ± 17.15 | −3.31 ± 2.99 | −2.23 ± 2.74 | 0.81* |
CRT (μm) | 489.4 ± 258.4 | 557.5 ± 197.5 | 517.5 ± 190.5 | 0.86* |
CCT (μm) | 210 ± 297 | 310 ± 317 | 518 ± 191 | 0.86* |
Duration from onset to treatment (days) | 18.7 ± 12.68 | 16.07 ± 11.20 | 19.25 ± 9.48 | 0.58* |